White paper peanut allergy: Part 3: management and therapy of peanut allergy

K. Blumchen*, A. Fischl, T. Eiwegger, E. Hamelmann, L. Klimek, L. Lange, Z. Szepfalusi, C. Vogelberg, K. Beyer

*Korrespondierende:r Autor:in für diese Arbeit

Publikation: Beitrag in Fachzeitschrift (peer-reviewed)Übersichtsartikel

2 Zitate (Scopus)

Abstract

The current management of a primary IgE-mediated peanut allergy consists of the two basic pillars “exposure prophylaxis” with avoidance of the allergen and “emergency therapy” with short-term treatment of an acute allergic reaction after accidental ingestion. Accidental reactions are common despite attempted avoidance. The severity of an allergic or even anaphylactic reaction after accidental ingestion is difficult to assess prior to reaction. In addition, reaction thresholds may vary depending on the accompanying augmentation factor. Therefore, every peanut allergic patient should receive individual dietary counseling as well as instructions for the use of the emergency kit and a structured patient education program (anaphylaxis group training), if necessary. For the first time, since fall 2021 a causal treatment option with a drug for oral immunotherapy will now be available for 4‑ to 17-year-old peanut-allergic children and adolescents. The oral immunotherapy with peanut protein as defatted powder of Arachis hypogaea L., semen (peanuts) leads to desensitization with a good efficacy record and an acceptable safety profile. Other treatment options with different therapeutic approaches are also under development and will probably expand the range for treatment in the coming years.

OriginalspracheEnglisch
Seiten (von - bis)69-80
Seitenumfang12
FachzeitschriftAllergo Journal International
Jahrgang31
Ausgabenummer3
DOIs
PublikationsstatusVeröffentlicht - Mai 2022

ASJC Scopus Sachgebiete

  • Immunologie und Allergologie

Fingerprint

Untersuchen Sie die Forschungsthemen von „White paper peanut allergy: Part 3: management and therapy of peanut allergy“. Zusammen bilden sie einen einzigartigen Fingerprint.

Dieses zitieren